# STOP (NCT02756793)

> Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02756793
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Conditions: Metastatic Cancer
- Interventions: Stereotactic Ablative Radiotherapy (SABR); Standard of Care Treatment
- Enrollment: 90
- Primary outcome: Progression-Free Survival

## Indexed commentary on STOP so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 26
- Podcasts: 8
- YouTube: 4

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=stop-nct02756793

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02756793", "email": "<work email>"}; the inbox owner confirms by the emailed link.